Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPT
Condition(s) studied
Study summary
For all countries, chronic liver disease and liver cirrhosis is one of the important disease burdens. Malnutrition is an important complication of liver cirrhosis, which always runs through the course of liver cirrhosis. According to a lot of scientific research evidence, as the consensus of experts all over the world, malnutrition in patients with liver cirrhosis is closely related to poor outcome. Therefore, early and accurate identification of the risk of malnutrition is very important to improve the prognosis of patients with liver cirrhosis.
The purpose of this study was to study the relationship between malnutrition-related indexes and prognosis in patients with liver cirrhosis. 2000 patients with liver cirrhosis were prospectively included, laboratory indexes related to malnutrition and other evaluation indexes were recorded, and long-term follow-up was made to observe the short-term and long-term prognosis of patients with liver cirrhosis. At the same time, a prognostic prediction model was established based on multivariate Cox regression, and a series of in-depth studies and verification were carried out on this basis.
Eligibility
Primary outcome measure(s)
- All-cause mortality — up to 10 years
All-cause mortality is death caused by any cause. - Liver-related mortality — up to 10 years
Liver-related mortality refers to death from any liver-related disease, such as liver cirrhosis, liver cancer and other related complications.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| First Affiliated Hospital Xi'an Jiaotong University | Xi'an | Shannxi |
More First Affiliated Hospital Xi'an Jiaotong University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05513651 on ClinicalTrials.gov ↗ ← All trials in China